Clinical reference Biomarker Directory
Back to directory

Coagulation Factor X

Established

Factor X deficiency can be hereditary or acquired via AL amyloidosis, where amyloid fibrils sequester the factor.

Also known as FX Stuart-Prower factor
In plain language

Factor X helps blood clot properly. A drop in factor X can be inherited, but it can also be a clue pointing toward an unrelated disease — amyloidosis — where a sticky protein soaks up factor X from the blood.

Biomarker & context

Factor X is a vitamin K-dependent clotting protein central to the common pathway of coagulation, activated by both the intrinsic and extrinsic clotting cascades.

What it indicates

Hereditary Factor X deficiency is a rare bleeding disorder, but an important acquired form occurs in AL (light chain) amyloidosis, where factor X binds to amyloid fibrils deposited in tissue and gets sequestered out of circulation.

Diagnosis & clinical testing

Diagnosed via specific factor X clotting assay when PT and aPTT are both prolonged; in a patient with unexplained bleeding and low factor X, amyloidosis should be considered as a possible underlying cause rather than assuming a primary bleeding disorder.

Guiding treatment

Treatment of acquired factor X deficiency in amyloidosis focuses on treating the underlying amyloid disease; hereditary deficiency may require factor replacement or prothrombin complex concentrates for bleeding episodes.

Clinical significance

Low factor X in an unexplained bleeding patient can be a diagnostic clue pointing toward amyloidosis.

References
  1. General hematology reference literature on acquired coagulation factor deficiencies in amyloidosis.